Biography:
Dr. Peter Facchini is the Chief Innovation Officer at Enveric Biosciences Inc. and a professor of biochemistry at the University of Calgary. He has held the Canada Research Chair in Metabolic Processes Biotechnology and has received awards for his achievements in innovation and entrepreneurship as the co-founder of four private and two publicly traded biotechnology companies. In addition to his work on psychedelics at Enveric Biosciences, his research has involved the complete elucidation of several medicinally important metabolic pathways, including the biosynthesis of morphine in opium poppy, and the reconstitution of these pathways in microorganisms.
Title : Design and synthesis of novel psilocin prodrugs with improved metabolic and pharmacokinetic properties as candidate therapies for treatment-resistant anxiety disorders